Close Menu
Home » Invitrogen

Invitrogen

Jan 10, 2008
Premium
Invitrogen has introduced PlateSelect RNAi duplexes, 96-well plates customizable with the company’s Stealth or Block-iT RNAi duplexes.
 
According to Invitrogen, the plates can be ordered online with anywhere from one to 96 different duplexes on a single plate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

From a Clay Pipe to Sierra Leone

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Shawl Analysis

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

Japan to Issue Gene-Edited Food Rules

Japan is to release rules governing some gene-edited food, according to NHK World.

This Week in PLOS

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.

Mar
21
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison (Part 2): Best NGS Approaches for Human Transcriptome Sequencing

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Apr
17
Featured Webinar

Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.

What's Popular?

In Gene Silencing/Gene Editing

  1. Mammoth Biosciences Licenses New CRISPR Enzyme for Disease Detection Applications

    Premium

  2. Broad Institute, Massachusetts General Hospital License CRISPR Tech to Pairwise

  3. NIH Expresses Support for Germline Editing Moratorium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.